Partnership Status and the Human Sex Ratio at Birth

If two-parent care has different consequences for the reproductive success of sons and daughters, then natural selection may favor adjustment of the sex ratio at birth according to circumstances that forecast later family structure. In humans, this partnership status hypothesis predicts fewer sons among extra-pair conceptions, but the rival "attractiveness" hypothesis predicts more sons among extra-pair conceptions, and the "fixed phenotype" hypothesis predicts a constant probability of having a son, regardless of partnership status. In a sample of 86,436 human births pooled from five US population-based surveys, I find 51.5% male births reported by respondents who were living with a spouse or partner before the child's conception or birth, and 49.9% male births reported by respondents who were not (X2=16.77, d.f. = 1, p

Anti-depressants and Suicide

Does drug treatment for depression with selective serotonin reuptake inhibitors (SSRIs) increase or decrease the risk of completed suicide? The question is important in part because of recent government warnings that question the safety of SSRIs, one of the most widely prescribed medications in the world. While there are plausible clinical and behavioral arguments that SSRIs could have either positive or negative effects on suicide, randomized clinical trials have not been very informative because of small samples and other problems. In this paper we use data from 26 countries for up to 25 years to estimate the effect of SSRI sales on suicide mortality using just the variation in SSRI sales that can be explained by cross-country variation in the growth of drug sales more generally. We find that an increase in SSRI sales of 1 pill per capita (about a 12 percent increase over 2000 sales levels) is associated with a decline in suicide mortality of around 5 percent. These estimates imply a cost per statistical life far below most other government interventions to improve health outcomes.

The Effects of Daycare Reconsidered

Do children of employed mothers differ from other children, even before mother's (re)entry to the labor force? Preexisting differences among children may be an alternative explanation for many apparent daycare outcome effects. Data from the 1994 wave of the National Longitudinal Survey of Youth were available for 6603 singleton infants followed from birth. Mothers of children with intrauterine growth retardation, birth defects, or extended hospitalization at birth began working significantly later after the birth of the child, and mothers of infants with higher development scores and more difficult temperament, and mothers of healthy premature infants, began working significantly earlier. The associations with newborn health persisted when the comparisons were made among siblings. The magnitudes of the effects were large enough to have practical importance. After controlling for both observed and unobserved differences between families, a mother was only 50% as likely to have been employed at all in the first five years after the birth of a high risk infant. About 20% of low-income newborns in the sample were classified as problems may therefore have resulted in a 10% lower labor force participation rate among low-income mothers of children under five.

Toxicity Evaluation of a Novel Magnetic Resonance Imaging Marker CoCl2-N-Acetylcysteine in Rats

C4 (cobalt dichloride-N-acetylcysteine [1% CoCl 2 :2% NAC]) is a novel magnetic resonance imaging contrast marker that facilitates visualization of implanted radioactive seeds in cancer brachytherapy. We evaluated the toxicity of C4. Rats were assigned to control (0% CoCl 2 :NAC), low-dose (0.1% CoCl 2 :2% NAC), reference-dose (C4), and high-dose (10% CoCl 2 :2% NAC) groups. Agent was injected into the left quadriceps femoris muscle of the rats. Endpoints were organ and body weights, hematology, and serum chemistry and histopathologic changes of tissues at 48 hours and 28 and 63 days after dosing. Student\u27s t tests were used. No abnormalities in clinical signs, terminal body and organ weights, or hematologic and serum chemistry were noted, and no gross or histopathologic lesions of systemic tissue toxicity were found in any treatment group at any time point studied. At the site of injection, concentration-dependent acute responses were observed in all treatment groups at 48 hours after dosing and were recovered by 28 days. No myofiber degeneration or necrosis was observed at 28 or 63 days in any group. In conclusion, a single intramuscular dose of C4 produced no acute or chronic systemic toxicity or inflammation in rats, suggesting that C4 may be toxicologically safe for clinical use in cancer brachytherapy

Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models

AbstractAge-related Macular Degeneration (AMD) is the leading cause of visual impairment and blindness in the elderly in developed countries. Neovascular/exudative (wet) AMD is the aggressive form of AMD and can involve choroidal neovascularization and vascular leakage. Anti-vascular endothelial growth factor (anti-VEGF) medications have significantly improved treatment of wet-AMD. However, only approximately 40% of patients obtain full benefit from anti-VEGF therapy and the medications are given by intravitreal injection. Axitinib, a small molecule multi-receptor tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma, is taken orally and inhibits VEGF activity by blocking VEGF receptors. Axitinib also has the advantage of blocking platelet derived growth factor (PDGF) receptors which play a role in neovascularization. Using in vitro human retinal microvascular endothelial cells (HRMVECs), human brain vascular pericytes (HBVRs), 3D co-culture vessel sprout assay, and in vivo laser induced rat choroidal neovascularization (CNV) models, the effect of axitinib on neovascularization was evaluated. Axitinib inhibited neovascularization better than anti-VEGF and/or anti-hPDGF-B mAb in the in vitro models demonstrating that combined inhibition of both VEGF and PDGF pathways may be synergistic in treating wet-AMD. Additionally, axitinib showed good efficacy at a low dose (0.875 mg/day) in laser-induced CNV model in rats. In conclusion our data shows that axitinib, an inhibitor of VEGF and PDGF-B pathways may be useful in ameliorating wet-AMD therapy

Galaxy Zoo: The Environmental Dependence of Bars and Bulges in Disc Galaxies

We present an analysis of the environmental dependence of bars and bulges in disc galaxies, using a volume-limited catalogue of 15810 galaxies at z<0.06 from the Sloan Digital Sky Survey with visual morphologies from the Galaxy Zoo 2 project. We find that the likelihood of having a bar, or bulge, in disc galaxies increases when the galaxies have redder (optical) colours and larger stellar masses, and observe a transition in the bar and bulge likelihoods, such that massive disc galaxies are more likely to host bars and bulges. We use galaxy clustering methods to demonstrate statistically significant environmental correlations of barred, and bulge-dominated, galaxies, from projected separations of 150 kpc/h to 3 Mpc/h. These environmental correlations appear to be independent of each other: i.e., bulge-dominated disc galaxies exhibit a significant bar-environment correlation, and barred disc galaxies show a bulge-environment correlation. We demonstrate that approximately half (50 +/- 10%) of the bar-environment correlation can be explained by the fact that more massive dark matter haloes host redder disc galaxies, which are then more likely to have bars. Likewise, we show that the environmental dependence of stellar mass can only explain a small fraction (25 +/- 10%) of the bar-environment correlation. Therefore, a significant fraction of our observed environmental dependence of barred galaxies is not due to colour or stellar mass dependences, and hence could be due to another galaxy property. Finally, by analyzing the projected clustering of barred and unbarred disc galaxies with halo occupation models, we argue that barred galaxies are in slightly higher-mass haloes than unbarred ones, and some of them (approximately 25%) are satellite galaxies in groups. We also discuss implications about the effects of minor mergers and interactions on bar formation.Comment: 20 pages, 18 figures; references updated; published in MNRA

Full production cycle performance of gene-edited, sterile Atlantic salmon - growth, smoltification, welfare indicators and fillet composition

Using germ cell-free (GCF), sterile, dnd-knockout salmon for farming could solve the problems associated with precocious maturation and genetic introgression of farmed breeds into wild populations. However, prior to using GCF fish in the salmon farming industry, it is crucial to understand if, or how, the GCF phenotype differs from wild type (WT) counterparts in terms of growth and welfare. To characterize the GCF phenotype throughout a production cycle, we reared GCF and WT salmon in indoor common garden tanks for 3 years, until harvest size. Regarding body size, smoltification markers (mRNA levels of gill Na+/K+-ATPase [NKA] subunits), plasma stress indicators (pH, glucose, sodium, chloride, calcium), relative heart size, prevalence of vertebra deformities and fillet proximate composition, GCF fish could not be distinguished from WTs. Transient differences were detected in plasma concentrations of lactate and osmolality, and only a few genes were differentially expressed in WT and GCF transcriptomes of muscle and pituitary. At harvest, fillets from GCF and WT salmon contained the same amount of omega-3 fatty acids, however the relative content of omega-3 fatty acids was higher in GCF compared to WT males. Towards harvest size, body growth rate, condition factor and relative liver size were significantly higher in WT than in GCF fish, probably relating to initiation of puberty in WTs. Since GCF salmon never become sexually mature, it is possible to postpone the time of harvest to exploit the growth potential uninhibited by sexual maturation. In conclusion, GCF salmon performed to a large extent similarly to their WT counterparts but had the clear advantage of never maturing.publishedVersio

Current ecotoxicity testing needs among selected U.S. federal agencies

U.S. regulatory and research agencies use ecotoxicity test data to assess the hazards associated with substances that may be released into the environment, including but not limited to industrial chemicals, pharmaceuticals, pesticides, food additives, and color additives. These data are used to conduct hazard assessments and evaluate potential risks to aquatic life (e.g., invertebrates, fish), birds, wildlife species, or the environment. To identify opportunities for regulatory uses of non-animal replacements for ecotoxicity tests, the needs and uses for data from tests utilizing animals must first be clarified. Accordingly, the objective of this review was to identify the ecotoxicity test data relied upon by U.S. federal agencies. The standards, test guidelines, guidance documents, and/or endpoints that are used to address each of the agencies’ regulatory and research needs regarding ecotoxicity testing are described in the context of their application to decision-making. Testing and information use, needs, and/or requirements relevant to the regulatory or programmatic mandates of the agencies taking part in the Interagency Coordinating Committee on the Validation of Alternative Methods Ecotoxicology Workgroup are captured. This information will be useful for coordinating efforts to develop and implement alternative test methods to reduce, refine, or replace animal use in chemical safety evaluations

Local Gravity versus Local Velocity: Solutions for β\beta and nonlinear bias

(abridged) We perform a reconstruction of the cosmological large scale flows in the nearby Universe using two complementary observational sets. The first, the SFI++ sample of Tully-Fisher (TF) measurements of galaxies, provides a direct probe of the flows. The second, the whole sky distribution of galaxies in the 2MASS redshift survey (2MRS), yields a prediction of the flows given the cosmological density parameter, $\Omega$, and a biasing relation between mass and galaxies. We aim at an unbiased comparison between the peculiar velocity fields extracted from the two data sets and its implication on the cosmological parameters and the biasing relation. We expand the fields in a set of orthonormal basis functions, each representing a plausible realization of a cosmological velocity field. Our analysis completely avoids the strong error covariance in the smoothed TF velocities by the use of orthonormal basis functions and employs elaborate realistic mock data sets to extensively calibrate the errors in 2MRS predicted velocities. We relate the 2MRS galaxy distribution to the mass density field by a linear bias factor, $b$, and include a luminosity dependent, $\propto L^\alpha$, galaxy weighting. We assess the agreement between the fields as a function of $\alpha$ and $\beta=f(\Omega)/b$, where $f$ is the growth factor of linear perturbations. The agreement is excellent with a reasonable $\chi^2$ per degree of freedom. For $\alpha=0$, we derive $0.28<\beta<0.37$ and $0.24<\beta<0.43$, respectively, at the 68.3% and 95.4% confidence levels (CLs). For $\beta=0.33$, we get $\alpha<0.25$ and $\alpha<0.5$, respectively, at the 68.3% and 95.4% CLs. We set a constraint on the fluctuation normalization, finding $\sigma_8 = 0.73 \pm 0.1$, in very good agreement with the latest WMAP results.Comment: MNRAS accepted versio